NEMOLIZUMAB-ILTO

15930 reported adverse events

Drug classes: Interleukin-31 Receptor alpha Antagonist [EPC]

These side effects are most commonly reported by patients taking NEMOLIZUMAB-ILTO:

# Side effect Count
0 PRODUCT DOSE OMISSION ISSUE 5792
1 DEVICE MALFUNCTION 2529
2 PRURITUS 1581
3 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1578
4 INCORRECT DOSE ADMINISTERED 1544
5 RASH 1056
6 DRUG INEFFECTIVE 947
7 DEVICE USE ERROR 658
8 DERMATITIS ATOPIC 556
9 HEADACHE 505
See all common reactions for NEMOLIZUMAB-ILTO

NEMOLIZUMAB-ILTO is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DYSKALAEMIA 1 0.1667
1 BREAST CYST RUPTURE 1 0.0833
2 NEURODERMATITIS 306 0.0821
3 PARADOXICAL SKIN REACTION 3 0.0682
4 ECZEMA WEEPING 8 0.0611
5 ECZEMA NUMMULAR 25 0.0511
6 DEVICE MALFUNCTION 2529 0.0360
7 STAPHYLOCOCCAL IMPETIGO 2 0.0351
8 TICK-BORNE FEVER 2 0.0299
9 SKIN WEEPING 98 0.0274
See all enriched reactions for NEMOLIZUMAB-ILTO